DK473988A - Fremgangsmaade til fremstilling af antigene fraktioner bestemt til paavisning af antistoffer, som roeb er en cardiovasculaer risiko, saaledes opnaaede antigene fraktioner og deres anvendelse til diagnose af en cardiovasculaer risiko - Google Patents

Fremgangsmaade til fremstilling af antigene fraktioner bestemt til paavisning af antistoffer, som roeb er en cardiovasculaer risiko, saaledes opnaaede antigene fraktioner og deres anvendelse til diagnose af en cardiovasculaer risiko

Info

Publication number
DK473988A
DK473988A DK473988A DK473988A DK473988A DK 473988 A DK473988 A DK 473988A DK 473988 A DK473988 A DK 473988A DK 473988 A DK473988 A DK 473988A DK 473988 A DK473988 A DK 473988A
Authority
DK
Denmark
Prior art keywords
fractions
anculaic
antibodies
diagnosis
procedure
Prior art date
Application number
DK473988A
Other languages
Danish (da)
English (en)
Other versions
DK473988D0 (da
Inventor
Israel Goldstein
Francous Noel Marie
Original Assignee
Diatech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diatech Sa filed Critical Diatech Sa
Publication of DK473988D0 publication Critical patent/DK473988D0/da
Publication of DK473988A publication Critical patent/DK473988A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rehabilitation Therapy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK473988A 1987-08-26 1988-08-25 Fremgangsmaade til fremstilling af antigene fraktioner bestemt til paavisning af antistoffer, som roeb er en cardiovasculaer risiko, saaledes opnaaede antigene fraktioner og deres anvendelse til diagnose af en cardiovasculaer risiko DK473988A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8711946A FR2619924B1 (fr) 1987-08-26 1987-08-26 Procede de preparation de fractions antigeniques destinees a la detection d'anticorps revelateurs d'un risque cardio-vasculaire, fractions antigeniques ainsi obtenues et leur utilisation pour le diagnostic d'un risque cardio-vasculaire

Publications (2)

Publication Number Publication Date
DK473988D0 DK473988D0 (da) 1988-08-25
DK473988A true DK473988A (da) 1989-02-27

Family

ID=9354438

Family Applications (1)

Application Number Title Priority Date Filing Date
DK473988A DK473988A (da) 1987-08-26 1988-08-25 Fremgangsmaade til fremstilling af antigene fraktioner bestemt til paavisning af antistoffer, som roeb er en cardiovasculaer risiko, saaledes opnaaede antigene fraktioner og deres anvendelse til diagnose af en cardiovasculaer risiko

Country Status (6)

Country Link
US (1) US5039608A (de)
EP (1) EP0306360A1 (de)
JP (1) JPH01250064A (de)
DK (1) DK473988A (de)
FR (1) FR2619924B1 (de)
PT (1) PT88336B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281700A (en) * 1992-08-11 1994-01-25 The Regents Of The University Of California Method of recovering endothelial membrane from tissue and applications thereof
WO1999057306A2 (en) * 1998-05-01 1999-11-11 Queen's University At Kingston Method for diagnosing a vascular condition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343734A (en) * 1980-01-10 1982-08-10 The Children's Hospital Medical Center Protein diagnostic for atherosclerosis
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
US4492753A (en) * 1982-10-06 1985-01-08 Immudx, Inc. Method and means for assessment and prediction of risk of subsequent ischemic cardiac events
JPS61130238A (ja) * 1984-11-30 1986-06-18 Res Dev Corp Of Japan 動脈硬化巣認識モノクロナル抗体および反応試薬

Also Published As

Publication number Publication date
FR2619924B1 (fr) 1989-12-29
FR2619924A1 (fr) 1989-03-03
PT88336A (pt) 1989-06-30
PT88336B (pt) 1993-09-30
US5039608A (en) 1991-08-13
JPH01250064A (ja) 1989-10-05
EP0306360A1 (de) 1989-03-08
DK473988D0 (da) 1988-08-25

Similar Documents

Publication Publication Date Title
NO915137D0 (no) Hittil ukjente antistoffer som er reaktive med humankarsinomer
DK318481A (da) Syntetisk peptid specifik antigenisk determinant og fremgangsmaade til fremstilling af antigene meneraler deraf
DK582189D0 (da) Fremgangsmaade til detektering af en specifik nucleinsyresekvens og diagnostisk testsaet til anvendelse ved fremgangsmaaden
DK198086A (da) Syntetisk peptid og fremgangsmaade til anvendelse af dette til paavisning af antistoffer mod htlv-iii, diagnosticering af aids og aids-forstadier og som vaccine mod aids og aids-forstadier
DE68914743D1 (de) Blutprobenröhrchen.
DK2189D0 (da) Kimaere antistoffer samt deres fremstilling og anvendelse
DK646587D0 (da) Fremgangsmaade til fremstilling af et technetium-99m-maerket organspecifikt stof, et ved fremstillingen egnet testkit, samt diagnostikum indeholdende det maerkede stof
IT8248474A0 (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
IT8222140A0 (it) Procedimento senza centrifugazione per prova immunologica dimateriali.
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
NO872174L (no) Fremgangsmaate for fremstilling av polypeptidpreparater med oekt biologisk tilgjengelighet.
DK419287D0 (da) Fremgangsmaade til fremstilling og anvendelse af faste, fytoaktive midler
DE3689948D1 (de) Monoklonale antikörper und testverfahren.
NO881215D0 (no) Fremgangsmaate for fremstilling av alger med forbedrete biologiske virkninger.
NO177463C (no) STLV-III-beslektede polypeptider, diagnostiske prövesett og in vitro analysefremgangsmåte for påvisning av anti-HIV-2-antistoffer i kroppsvæskepröve
DK473988D0 (da) Fremgangsmaade til fremstilling af antigene fraktioner bestemt til paavisning af antistoffer, som roeb er en cardiovasculaer risiko, saaledes opnaaede antigene fraktioner og deres anvendelse til diagnose af en cardiovasculaer risiko
DK331688D0 (da) Apparat til undersoegelse af leverfunktionen
DK517187A (da) Kobling samt fremgangsmaade til fremstilling af en saadan kobling for et roerformet organ, der omfatter en forstaerkningsarmering
NO883626L (no) Fremgangsmaate for diagnose av kikhoste og testsett for utfoerelse av fremgangsmaaten.
ES539638A0 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
DK70488D0 (da) Fremgangsmaade til paavisning af antistoffer i blod, samt membran og test-saet til anvendelse ved udoevelse af fremgangsmaaden
DK120789D0 (da) 4-pentafluorphenoxupiperidiner, en fremgangsmaade til deres fremstilling og anvendelse af disse som laegemiddel
DK407288D0 (da) Apparat til bestemmelse af en blodproeves blodtype
ZA903854B (en) Diagnostic test for detecting antibodies directed against antigens of one or more related viruses
DE3788424D1 (de) Testverfahren des menschlichen b-lymphotropen virus (hblv).

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment